RE:RE:RE:RE:BESThe valuation metrics have become fuzzy because the management strategy is completely unclear.
What do Shareholders actually know about the company's plans going forward? Management disclosure is negligible. Forecasts don't exist. News flow re Lac Knife is next to nothing. Participants keep hoping against hope that the company's association with Grafoid is the key to consolidating and unlocking value. Maybe so...but arm-chair corporate strategists aren't in charge. So what is this management team really up to? I simply can't tell and guessing isn't worthwhile.
I've been in this thing for more than 10 years. The flakes may be promising but management appears rather flakey. If they have a grand strategy about to unfold which will see me recoup my basis....and possibly make a return some day...god bless 'em. But there is very little firm action upon which to pin such hope. Graphene applications may be the future but I don't see FCMSF in the mix. Dejected in London!